Article Details
Retrieved on: 2024-04-16 18:43:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Prasinezumab, a monoclonal antibody targeting alpha-synuclein aggregation, shows promise in slowing motor deterioration in rapidly progressing ...
Article found on: neurosciencenews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here